Syövänhoidon vastuualue

Julkaisut 2018 (alustava)
Publications 2018 (preliminary)

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Ahlgren G et al. Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer: Results from the Prospective Randomised. Open-label Phase 3 Scandinavian Prostate Cancer Group 12 Trial.
2 Ali A et al. Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3).
3 Aula H et al. Decreases in TGF-ß1 and PDGF levels are associated with echocardiographic changes during adjuvant radiotherapy for breast cancer.
4 Boman E et al. Monte Carlo investigation on the effect of air gap under bolus in post-mastectomy radiotheraphy.
5 Boman E et al. Dosimetric comparison of surface mould HDR brachytherapy with VMAT.
6 Chaikc A et al. Dosimetrical and radiobiological approach to manage the dosimetric shift in the transition of dose calculation algorithm in radiation oncology: how to improve high quality treatment and avoid unexpected outcomes?
7 Gillessen S et al. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017.
8 Haltia O et al. The indirect costs of palliative care in end-stage cancer: A real-life longitudinal register- and questionnaire-based study.
9 Hermunen K et al. Can carcinoembryonic antigen replace computed tomography in response evaluation of metastatic colorectal cancer?
10 Hietanen T et al. Natural Killer Cell Viability After Hyperthermia Alone or Combined with Radiotherapy with or without Cytokines.
11 Joensuu H et al. Effect of Adjuvant Trastuzumab for a Duration of 9 Weeks vs 1 Year With Concomitant Chemotherapy for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: The SOLD Randomized Clinical Trial.
12 Joensuu H et al. Effect of Adjuvant Trastuzumab for a Duration of 9 Weeks vs 1 Year With Concomitant Chemotherapy for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer. The SOLD Randomized Clinical Tria.
13 Kaikkonen E et al. ANO7 is associated with aggressive prostate cancer.
14 Koivumäki T et al. Dosimetric evaluation of modern radiation therapy techniques for left breast in deep-inspiration breath-hold.
15 Korpi S et al. Therapeutic Procedures for Malignant Ascites in a Palliative Care Outpatient Clinic.
16 Koski K et al. Simulated Encounters With Vaccine-Hesitant Parents: Arts-Based Video Scenario and a Writing Exercise.
17 Luhtala S et al. Comparison of Antibodies for Immunohistochemistry-based Detection of HER3 in Breast Cancer.
18 Luhtala S et al. Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4-1 and NRDP1, in primary breast cancer.
19 Motzer R et al. Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.
20 Mäkitie A et al. The management and survival outcomes of nasopharyngeal cancer in the Nordic countries.
21 Pajamäki N et al. Long-term cardiovascular morbidity and mortality in patients treated for differentiated thyroid cancer.
22 Piili R et al. Does special education in palliative medicine make a difference in end-of-life decision-making?
23 Piili R et al. Changes in attitudes towards hastened death among Finnish physicians over the past sixteen years.
24 Pollari M et al. PD-L1+ tumor-associated macrophages and PD-1+ tumor-infiltrating lymphocytes predict survival in primary testicular lymphoma.
25 Prusila REI et al. R-Bendamustine in the treatment of nodular lymphocyte-predominant Hodgkin lymphoma.
26 Rahko E, Lehto J. Eutanasia.
27 Rajala K et al. Marked deterioration in the quality of life of patients with idiopathic pulmonary fibrosis during the last two years of life.
28 Rossi M et al. Dosimetric effects of anatomical deformations and positioning errors in VMAT breast radiotherapy.
29 Ruuskanen M et al. Outcome of nasopharyngeal carcinoma in Finland: A nationwide study.
30 Saarto T et al. Palliatiivinen hoito ja saattohoito. Päivitystiivistelmä.
31 Schmidt M et al. Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population.
32 Sormunen J. Physical Activity and Incidence of Cancer with Special Emphasis on Colorectal and Prostate Cancers in Men.
33 Sormunen J et al. Perceived Physical Strain at Work and Incidence of Prostate Cancer – a Case-Control Study in Sweden and Finland.
34 Sperinde J et al. p95HER2 Methionine 611 Carboxy-Terminal Fragment Is Predictive of Trastuzumab Adjuvant Treatment Benefit in the FinHer Trial.
35 Sunela K. Solunsalpaajahoitojen jälkeiset myöhäishaitat.
36 Talibov M et al. Benzene exposure at workplace and risk of colorectal cancer in four Nordic countries.
37 Tuohinen S et al. Radiotherapy-induced Early ECG Changes and Their Comparison with Echocardiography in Patients with Early-stage Breast Cancer.
38 Tuohinen S et al. Associations between ECG changes and echocardiographic findings in patients with acute non-ST elevation myocardial infarction.
39 Tuohinen S et al. Syövän hoitojen sydänvaikutukset.
40 Vanhanen A et al. Localization accuracy of two electromagnetic tracking systems in prostate cancer radiotheraphy: A comparison with fiducial marker based kilovoltage imaging.
41 Viitala A et al. The Coping and Support Needs of Incurable Cancer Patients.
42 Vänskä M et al. Osaatko epäillä hemofagosyyttistä lymfohistiosytoosia?
43 Wu X et al. Dynamic Contrast-Enhanced Imaging as a Prognostic Tool in Early Diagnosis of Prostate Cancer: Correlation with PSA and Clinical Stage.

Julkaisutietokanta 31.12.2019 Publications Data Base 31.12.2019